title: Abortive migraine therapy with oral naproxen sodium plus metoclopramide plus ergotamine tartrate with caffeine.
abstract: The oral tablet combination, (550 mgs. of naproxen sodium plus 10 mgs. of metoclopramide plus 1 mg. of ergotamine tartrate plus 100 mgs. of caffeine), was retrospectively studied in 63 patients who used it to abort migraine headaches. On the average, 84% of the headaches were totally aborted; minor side effects occurred in 40% of the patients, and 87% of the patients considered the combination superior to all prior treatments.
authors.affiliation: Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City.
authors.forename: H A
authors.initials: HA
authors.lastname: Saadah
mesh_terms: D000328:Adult; D002110:Caffeine / Q000627:therapeutic use*; D004338:Drug Combinations; D004878:Ergotamine / Q000627:therapeutic use*; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use*; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D009288:Naproxen / Q000627:therapeutic use*; D012189:Retrospective Studies
chemical_list: D004338:Drug Combinations; D002110:Caffeine; D009288:Naproxen; D008787:Metoclopramide; D004878:Ergotamine